The Role of Dopamine in Gastric Cancer—A Systematic Review of the Pathogenesis Phenomena Developments
Authors:
- Radu-Cristian CimpeanuRCRadu-Cristian Cimpeanu
- Dragoș FortofoiuDFDragoș Fortofoiu
- Elena SanduESElena Sandu
- Ioana-Gabriela DragneIDIoana-Gabriela Dragne
- Mariana-Emilia CarageaMCMariana-Emilia Caragea
- Roxana-Ioana Dumitriu-StanRDRoxana-Ioana Dumitriu-Stan
- Bianca-Margareta SalmenBSBianca-Margareta Salmen
- Lidia BoldeanuLBLidia Boldeanu
- Delia Viola Reurean-PintileiDelia Viola Reurean-Pintilei
- Cristin-Constantin VereCVCristin-Constantin Vere
Open Access
- 7 December 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (12) , 2786
Abstract
Background: In the last few decades, it has been emphasized that dopamine, a well-known neurotransmitter with multiple roles in central nervous system, is also implicated in the activity of peripheral tissues and organs, more specifically influencing the gastrointestinal system (GI). Methods: We registered a protocol under the CRD42024547935 identifier in the Prospero register of systematic reviews. Furthermore, using the Population, Intervention, Comparison, Outcome, and Study Design strategy to guide our study rationale, and under the Preferred Reporting Items for Systematic reviews and Meta-Analyses recommendations, we conducted a qualitative systematic literature search based on the PubMed, Scopus, and Web of Science databases using the “gastric cancers AND dopamine” search criteria. We obtained 68 articles from PubMed, 142 articles from Scopus, and 99 articles from the Web of Science database. Results: Within gastric cancer biology, dopamine has notable effects on STAT-3 and DARPP-32. STAT-3, a transcription factor involved in cellular proliferation and invasion, plays a significant role in cancer progression. Conclusions: Understanding the roles of dopamine in cancer, beyond aspects such as cancer cell invasion, immune response modulation, or tumor growth, could guide the development of new cancer therapies by modulating its pathways, especially the DARPP-32/CXCR4/CXCL-12 complex axis, in order to improve the morbidity and mortality caused by this type of cancer.Keywords
Funding Information
- University of Medicine and Pharmacy of Craiova, Romania
This publication has 51 references indexed in Scilit:
- The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compoundsBiomedicine & Pharmacotherapy, 2024
- Dopamine receptors gene overexpression in the microenvironment of invasive gastric cancer and its potential implicationsMolecular Biology Reports, 2023
- Vagus innervation in the gastrointestinal tumor: Current understanding and challengesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and AdenocarcinomaJAMA Network Open, 2021
- Hypoxia: Turning vessels into vassals of cancer immunotoleranceCancer Letters, 2020
- The A to Z of modulated cell patterning by mammalian thioredoxin reductasesFree Radical Biology and Medicine, 2018
- Management of gastric neuro-endocrine tumours in a large French national cohort (GTE)Endocrine, 2017
- Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathwayInternational Immunopharmacology, 2016
- The immunoregulatory role of dopamine: An updateBrain, Behavior, and Immunity, 2010
- Alteration of Dopamine D2 Receptors in Human Malignant Stomach TissueDigestive Diseases and Sciences, 1997